10x Genomics (TXG)
Builds Chromium, Visium, Xenium, and Atera platforms for single-cell and spatial biology.
$80.98
After hours+0.28 (+0.35%)
At close$80.70(+2.02%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 101.43% | 129.58M shares | |
|---|---|---|---|
| 403 holders · as of Jun 30, 2026 | |||
| Insiders | 1.25% | 1.59M shares | |
| 9 holders · as of Sep 11, 2026 | |||
| Adds to | 102.68% | ||
127.75M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 102.68%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
403 holders · 129.58M shares · 102 new positions · 203 increased · 141 reduced · 40 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 17.63M | 13.80% | −111.7K | Aug 13, 2026 |
| BlackRock, Inc. | 10.80M | 8.46% | +724.2K | Aug 7, 2026 |
| Ark Investment Management LLC | 10.00M | 7.83% | −1.71M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.98M | 5.47% | +69.6K | Aug 13, 2026 |
| Quantinno Capital Management LP | 5.47M | 4.28% | +57.9K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 5.08M | 3.98% | −187.0K | Aug 13, 2026 |
| Price T Rowe Associates Inc /MD/ | 4.54M | 3.55% | +4.38M | Aug 14, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 4.19M | 3.28% | −915.6K | Jul 30, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 15.60% | 18.54M | 13G | Mar 6, 2026 |
| T. Rowe Price Associates, Inc. | 11.70% | 14.04M | 13G | Sep 8, 2026 |
| ARK Investment Management LLC | 10.39% | 11.89M | 13G | Nov 4, 2025 |
| BlackRock, Inc. | 7.60% | 8.50M | 13G | Jul 16, 2025 |
| Sumitomo Mitsui Trust Group, Inc. (“SMTG”)incl. Nikko Asset Management Co., Ltd. (“NAM”) | 5.98% | 6.37M | 13G | Nov 5, 2024 |
| Vanguard Portfolio Management | 5.93% | 6.98M | 13G | Apr 28, 2026 |
| Nikko Asset Management Americas, Inc. | 5.40% | 6.01M | 13G | Aug 13, 2025 |
| Vanguard Capital Management | 5.24% | 6.17M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 9, 2026 | Adam Taichofficer: Chief Financial Officer | Sale · 3 lots | 46,388 | $64.57 | 316,344 |
| Sep 3, 2026 | John R. Stuelpnageldirector | Sale · 3 lots | 20,000 | $61.75 | 328,436 |
| Aug 26, 2026 | Serge Saxonovdirector, officer: Chief Executive Officer | Sale · 3 lots | 10,486 | $63.69 | 1,075,349 |
| Aug 24, 2026 | Adam Taichofficer: Chief Financial Officer | Sale | 17,166 | $63.02 | 362,732 |
| Aug 24, 2026 | Serge Saxonovdirector, officer: Chief Executive Officer | Sale | 18,545 | $63.02 | 1,085,835 |
| Aug 24, 2026 | Shehnaaz Sulimandirector | Sale · 2 lots | 2,207 | $63.65 | 29,515 |
| Aug 24, 2026 | Benjamin J. Hindsondirector, officer: See Remarks | Sale | 13,818 | $63.02 | 488,182 |
| Aug 14, 2026 | Sarah A. Teichmanndirector | Sale | 2,273 | $57.15 | 28,058 |
| Aug 13, 2026 | Sarah A. Teichmanndirector | Sale | 5,278 | $57.29 | 30,331 |
| Aug 11, 2026 | John R. Stuelpnageldirector | Sale · 2 lots | 20,000 | $57.75 | 348,436 |
House and Senate disclosures
Not reported.